Lee Financial CO Viatris Inc Transaction History

Lee Financial CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 08, 2024	SELL	$8.77 - $10.85 $359 - $444	-41 Reduced 8.58%	437 $4,000
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $2,511 - $3,346	273 Added 133.17%	478 $4,000
Q4 2022 Feb 09, 2023	BUY	$8.72 - $11.56 $1,386 - $1,838	159 Added 345.65%	205 $2,000
Q3 2022 Nov 01, 2022	SELL	$8.48 - $11.13 $2,747 - $3,606	-324 Reduced 87.57%	46 $0
Q2 2022 Aug 10, 2022	BUY	$9.95 - $12.27 $3,124 - $3,852	314 Added 560.71%	370 $4,000
Q1 2022 May 11, 2022	SELL	$9.81 - $15.4 $578 - $908	-59 Reduced 51.3%	56 $1,000
Q2 2021 Aug 04, 2021	SELL	$12.97 - $16.15 $700 - $872	-54 Reduced 31.95%	115 $2,000
Q1 2021 May 13, 2021	SELL	$13.59 - $18.54 $1,399 - $1,909	-103 Reduced 37.87%	169 $2,000
Q4 2020 Feb 12, 2021	BUY	$14.3 - $18.74 $3,889 - $5,097	272 New	272 $5,000

1,103

931M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $14.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Lee Financial CO, based on Form 13F filings with the SEC.

Stay updated on Lee Financial CO with notifications on news.